{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-005554","form_type":"8-K","ticker":"ORGO","cik":"0001661181","company_name":"Organogenesis Holdings Inc.","filed_at":"2023-03-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.047336+00:00","generated_at":"2026-06-18T18:10:50.916501+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Organogenesis Q4 revenue down 10% YoY; FY2023 guidance flat to +2%","bullets":["Q4 2022 net revenue $115.5M (-10% YoY); net income $7.5M vs $51.0M in Q4 2021.","FY2022 net revenue $450.9M (-4% YoY); net income $15.5M vs $94.2M in FY2021.","FY2023 guidance: revenue $450-462M (flat to +2%); net income $7.2-13.9M.","PuraPly revenue expected to decline 18-26% in FY2023 to $180-200M.","Adjusted EBITDA FY2023 guidance $36.5-46.0M vs $49.3M in FY2022."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-005554","json":"https://secwatch.observer/filing/0000950170-23-005554.json","markdown":"https://secwatch.observer/filing/0000950170-23-005554.md","text":"https://secwatch.observer/filing/0000950170-23-005554.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661181/000095017023005554/0000950170-23-005554-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661181/000095017023005554/orgo-20230301.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T18:10:50.916501+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"08958eb01da837ddeaee1a157f0b63ec79c1e235","claim":"Organogenesis Holdings Inc. reported the fourth quarter ended December 31, 2022 results: revenue $115.5 million, net income $7.5 million, EPS $0.06 per share. Guidance initiated.","evidence_excerpt":"Medicine markets, today reported financial results for the fourth quarter and the year ended December 31, 2022. Fourth Quarter 2022 Financial Results Summary: • Net revenue of $115.5 million for the fourth quarter of 2022, a decrease of 10% compared to net revenue of $127.9 million for the fourth quarter of 2021. Net revenue for the fourth quarter of 2022 consists","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661181/000095017023005554/0000950170-23-005554-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$115.5 million"},{"label":"Net income","value":"$7.5 million"},{"label":"EPS","value":"$0.06 per share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"70649684602bcf9c3f1ef3754a89c78827827dee","claim":"Organogenesis Holdings Inc. reported the year ended December 31, 2022 results: revenue $450.9 million, net income $15.5 million. Guidance initiated.","evidence_excerpt":"of 2022, compared to Adjusted EBITDA of $26.3 million for the fourth quarter of 2021, a decrease of $12.3 million. Fiscal Year 2022 Financial Results Summary: • Net revenue of $450.9 million for the year ended December 31, 2022, a decrease of 4% compared to net revenue of $467.4 million for the year ended December 31, 2021. Net revenue for the year ended December 31,","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661181/000095017023005554/0000950170-23-005554-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2022"},{"label":"Revenue","value":"$450.9 million"},{"label":"Net income","value":"$15.5 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}